RecallHawk
Class III Recall

Xolegel (ketoconazole) gel 2%, 45 gram tubes, Rx only, Manufactured by: DPT Laboratories, San Antonio, TX 78215, NDC 161

ALMIRALL, LLC

Summary

The FDA issued a Class III for Xolegel (ketoconazole) gel 2%, 45 gram tubes, Rx only, Manufactured by: DPT Labo by ALMIRALL, LLC. Reason: Failed Viscosity specification: Slightly higher OOS results obtained for viscosity.

Details

Source

Drug Recall

External ID

D-1549-2022

Action Date

2022-10-05

Status

Terminated

Category

drug

Product Description

Xolegel (ketoconazole) gel 2%, 45 gram tubes, Rx only, Manufactured by: DPT Laboratories, San Antonio, TX 78215, NDC 16110-080-45

Lot/Code Info: Lot #: RGAF, Exp. Date 12/2022

Quantity Affected: 5,315 tubes

Reason for Recall

Failed Viscosity specification: Slightly higher OOS results obtained for viscosity

Distribution

Nationwide within the United States

Type: Voluntary: Firm initiated

Recall Initiated: 2022-09-16

Company

ALMIRALL, LLC

Malvern, PA

Context & Analysis

This is a Class III recall. Class III recalls involve products unlikely to cause adverse health consequences, but that violate FDA regulations.

This was one of 21 drug recalls issued in the same week, part of 267 drug-related FDA actions this month.

Frequently Asked Questions

What is a Class III recall?

A Class III recall involves products that are unlikely to cause adverse health effects but violate FDA labeling or manufacturing regulations.

What should I do if I have this product?

Stop using the product. Check the product against the specific lot numbers or identifiers listed in the recall. Contact the manufacturer (ALMIRALL, LLC) or your retailer for a refund or replacement. If you experienced adverse effects, report them to the FDA via MedWatch.

How often does ALMIRALL, LLC have FDA actions?

This is the only FDA action we have on record for ALMIRALL, LLC in our database.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "D-1549-2022" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions